MindImmune Co. Awarded $85,000 to Abdeltawab Hendawi for Development of machine learning/artificial intelligence-based data analysis tools to assess phenotypes in mouse models of neurodegenerative diseases. Machine learning and artificial intelligence (ML/AI) tools are increasingly used to develop deep behavioral descriptors of phenotypes in mouse models of neurodegenerative and neuropsychiatric disease.